Daniel Slane was reappointed to the Commission by Speaker of the House Paul Ryan for a two-year term expiring on December 31, 2017. Commissioner Slane served as the Commission’s Chairman for the 2010 Report cycle and as Vice Chairman for the 2011 Report cycle.
Commissioner Slane served for two years on active duty as a U.S. Army Captain in Military Intelligence; in addition he served for a number of years as a Case Officer with the U.S. Central Intelligence Agency. Commissioner Slane worked in The White House during the Ford Administration.
In 1996, Commissioner Slane became a member of the board of trustees of The Ohio State University and was chairman from 2005 to 2006. The Ohio State University is the nation’s largest university, with an annual budget of over $4 billion. He is also the former chairman of University Hospital, a 1,000-bed regional hospital in Columbus, and the former chairman of the James Cancer Hospital, a National Cancer Institute Comprehensive Cancer Center. Commissioner Slane serves on the board of two financial institutions and a number of nonprofit organizations.
Commissioner Slane is the founder and co-owner of the Slane Company, whose principal business includes real estate development, lumber, and furniture. He has extensive international business experience, including operating a business in China. Prior to becoming a member of the Commission, Commissioner Slane manufactured plywood and related wood products at factories in Harbin, Dalian, and Balu (Pizhou), China. In 2007, he sold his interest in that company.
Commissioner Slane received a Bachelor of Science in Business Administration and a Juris Doctorate from The Ohio State University. He holds a Master’s Degree in International Law from the Europa Institute at the University of Amsterdam in The Netherlands. Commissioner Slane is a member of the Ohio Bar and was formerly a partner in the law firm of Grieser, Schafer, Blumenstiel, and Slane.
The U.S.-China Economic and Security Review Commission was created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.